From DNA to drugs. Novartis Foundation Symposium. From genome to therapy: integrating new technologies with drug development.
Melton
L
L
The Novartis Foundation, London, UK. lmelton@novartisfound.org.uk
D000818:Animals; D002986:Clinical Trials as Topic; D015195:Drug Design; D015180:Electrophoresis, Gel, Two-Dimensional; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D015894:Genome, Human; D006801:Humans; D008288:Malaria / Q000517:prevention & control; D017780:Malaria Vaccines; D013058:Mass Spectrometry / Q000379:methods; D010963:Plasmodium falciparum / Q000235:genetics / Q000276:immunology; D017354:Point Mutation; D011110:Polymorphism, Genetic; D020539:Sequence Analysis, Protein / Q000295:instrumentation / Q000379:methods
D017780:Malaria Vaccines